| Lactose (India) Ltd | 128 Cr. | 102 | 188/84.3 | 28.3 | 49.6 | 0.00 % | 12.9 % | 9.69 % | 10.0 |
| MPS Pharmaa Ltd | 3.21 Cr. | 1.68 | 4.29/1.68 | | 0.33 | 0.00 % | 9.79 % | 59.0 % | 10.0 |
| Gujarat Themis Biosyn Ltd | 3,527 Cr. | 324 | 479/192 | 73.8 | 24.3 | 0.21 % | 27.3 % | 21.7 % | 1.00 |
| Gujarat Terce Laboratories Ltd | 32.8 Cr. | 44.2 | 82.0/37.2 | | 10.6 | 0.00 % | 41.4 % | 14.6 % | 10.0 |
| Gujarat Inject (Kerala) Ltd | 79.0 Cr. | 53.9 | 54.0/17.0 | 188 | 6.93 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
| Godavari Drugs Ltd | 70.2 Cr. | 93.2 | 115/69.7 | 19.0 | 60.3 | 0.00 % | 10.1 % | 10.6 % | 10.0 |
| Glenmark Life Sciences Ltd | 54,514 Cr. | 1,935 | 2,286/1,275 | 20.1 | 340 | 0.13 % | 19.4 % | 15.8 % | 1.00 |
| Gennex Laboratories Ltd | 295 Cr. | 12.2 | 17.2/10.8 | 17.7 | 8.79 | 0.00 % | 13.0 % | 10.2 % | 1.00 |
| Ganga Pharmaceuticals Ltd | 7.09 Cr. | 12.0 | 14.8/9.25 | 88.6 | 14.0 | 0.00 % | 3.18 % | 1.13 % | 10.0 |
| Fredun Pharmaceuticals Ltd | 884 Cr. | 1,648 | 1,999/635 | 30.6 | 334 | 0.04 % | 18.9 % | 15.8 % | 10.0 |
| Fervent Synergies Ltd | 101 Cr. | 20.1 | 29.8/17.0 | 29.1 | 10.8 | 0.00 % | 7.47 % | 7.47 % | 10.0 |
| Fermenta Biotech Ltd | 966 Cr. | 328 | 449/219 | 8.62 | 133 | 0.76 % | 23.0 % | 24.9 % | 5.00 |
| Fabino Enterprises Ltd | 2.89 Cr. | 13.8 | 39.0/13.0 | | 19.2 | 0.00 % | 7.16 % | 3.08 % | 10.0 |
| Evoq Remedies Ltd | 8.14 Cr. | 3.27 | 8.28/2.11 | 4.63 | 17.9 | 0.00 % | 0.35 % | 0.26 % | 10.0 |
| Everest Organics Ltd | 400 Cr. | 412 | 536/211 | 60.4 | 74.7 | 0.00 % | 1.76 % | 2.23 % | 10.0 |
| Entero Healthcare Solutions Ltd | 4,960 Cr. | 1,141 | 1,511/944 | 44.9 | 406 | 0.00 % | 8.71 % | 5.63 % | 10.0 |
| Murae Organisor Ltd | 51.1 Cr. | 0.25 | 1.12/0.20 | 3.36 | 1.02 | 0.00 % | 4.20 % | 5.69 % | 1.00 |
| Dipna Pharmachem Ltd | 33.4 Cr. | 12.7 | 26.3/11.2 | 16.3 | 24.5 | 0.00 % | 6.64 % | 2.55 % | 10.0 |
| Decipher Labs Ltd | 7.82 Cr. | 7.75 | 14.8/7.50 | | 19.0 | 0.00 % | 4.67 % | 1.16 % | 10.0 |
| Coral Laboratories Ltd | 163 Cr. | 455 | 851/415 | 9.21 | 596 | 0.33 % | 17.4 % | 13.1 % | 10.0 |
| Concord Drugs Ltd | 78.0 Cr. | 78.0 | 92.5/26.1 | 147 | 34.4 | 0.00 % | 4.73 % | 0.88 % | 10.0 |
| Concord Biotech Ltd | 13,892 Cr. | 1,327 | 2,452/1,100 | 43.2 | 174 | 0.81 % | 28.4 % | 21.4 % | 1.00 |
| Colinz Laboratories Ltd | 8.00 Cr. | 63.5 | 88.7/36.1 | 16.3 | 39.2 | 0.00 % | 6.72 % | 5.43 % | 10.0 |
| Cian Healthcare Ltd | 12.5 Cr. | 5.01 | 7.66/2.99 | | 13.0 | 0.00 % | 10.6 % | 30.3 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 17.0 Cr. | 113 | 153/63.0 | | 9.60 | 0.00 % | 5.17 % | 3.47 % | 10.0 |
| Checkpoint Trends Ltd | 57.8 Cr. | 106 | 144/12.1 | 28.1 | 3.60 | 0.00 % | 16.5 % | 9.17 % | 10.0 |
| Chandra Bhagat Pharma Ltd | 31.8 Cr. | 42.2 | 73.0/33.0 | 51.4 | 40.3 | 0.00 % | 6.00 % | 2.41 % | 10.0 |
| Brawn Biotech Ltd | 5.55 Cr. | 18.5 | 24.4/15.5 | | 12.3 | 0.00 % | 42.5 % | 41.3 % | 10.0 |
| Blue Jet Healthcare Ltd | 7,130 Cr. | 411 | 1,028/392 | 20.2 | 72.4 | 0.29 % | 39.8 % | 30.2 % | 2.00 |
| Bharat Immunological & Biological Corporation Ltd | 87.0 Cr. | 20.2 | 28.8/16.6 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
| Beryl Drugs Ltd | 11.0 Cr. | 21.7 | 36.0/17.4 | 47.8 | 18.6 | 0.00 % | 10.2 % | 6.30 % | 10.0 |
| Mankind Pharma Ltd | 84,958 Cr. | 2,060 | 2,727/2,029 | 48.1 | 376 | 0.05 % | 15.0 % | 13.9 % | 1.00 |
| BDH Industries Ltd | 220 Cr. | 382 | 524/241 | 22.6 | 123 | 1.18 % | 17.8 % | 14.2 % | 10.0 |
| Bacil Pharma Ltd | 53.1 Cr. | 37.0 | 47.9/26.7 | 83.0 | 18.4 | 0.00 % | 0.97 % | 0.98 % | 10.0 |
| Aurobindo Pharma Ltd | 69,121 Cr. | 1,191 | 1,279/994 | 20.2 | 603 | 0.34 % | 14.2 % | 11.1 % | 1.00 |
| Auro Laboratories Ltd | 168 Cr. | 270 | 303/159 | 57.0 | 69.9 | 0.00 % | 3.85 % | 4.33 % | 10.0 |
| Anuh Pharma Ltd | 794 Cr. | 79.3 | 115/68.0 | 19.0 | 32.6 | 1.89 % | 17.2 % | 13.4 % | 5.00 |
| ANG Lifesciences India Ltd | 34.3 Cr. | 26.3 | 42.5/21.0 | | 50.0 | 0.00 % | 3.54 % | 13.8 % | 10.0 |
| Acutaas Chemicals Ltd | 16,227 Cr. | 1,987 | 2,061/930 | 56.6 | 173 | 0.08 % | 19.9 % | 16.0 % | 5.00 |
| Amerise Biosciences Ltd | 5.02 Cr. | 0.76 | 1.06/0.51 | 71.7 | 0.81 | 0.00 % | 0.19 % | 0.19 % | 1.00 |
| Ambalal Sarabhai Enterprises Ltd | 195 Cr. | 25.4 | 53.8/23.1 | 12.5 | 19.2 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
| Adline Chem Lab Ltd | 8.63 Cr. | 14.8 | 19.1/7.60 | | 2.75 | 0.00 % | % | % | 10.0 |
| Achyut Healthcare Ltd | 129 Cr. | 5.47 | 6.57/2.82 | | 1.33 | 0.00 % | 2.26 % | 1.77 % | 1.00 |
| Abbott India Ltd | 58,108 Cr. | 27,365 | 37,000/26,430 | 38.5 | 1,888 | 1.74 % | 46.2 % | 35.7 % | 10.0 |
| Aarti Pharmalabs Ltd | 7,041 Cr. | 777 | 972/557 | 29.4 | 226 | 0.64 % | 17.4 % | 14.5 % | 5.00 |
| Aarey Drugs & Pharmaceuticals Ltd | 189 Cr. | 67.2 | 100/31.3 | 52.9 | 52.5 | 0.00 % | 6.38 % | 2.96 % | 10.0 |
| Zota Health Care Ltd | 4,338 Cr. | 1,284 | 1,740/752 | | 93.5 | 0.08 % | 17.0 % | 36.0 % | 10.0 |
| Wockhardt Ltd | 22,720 Cr. | 1,398 | 1,870/1,110 | 414 | 281 | 0.00 % | 3.75 % | 1.22 % | 5.00 |
| Wanbury Ltd | 852 Cr. | 245 | 330/154 | 19.8 | 18.1 | 0.00 % | 36.7 % | 76.5 % | 10.0 |
| Vivimed Labs Ltd | 59.7 Cr. | 7.21 | 29.4/6.65 | | 5.79 | 0.00 % | 8.10 % | % | 2.00 |
| Venus Remedies Ltd | 978 Cr. | 734 | 873/278 | 12.8 | 445 | 0.00 % | 11.1 % | 7.16 % | 10.0 |
| Unichem Laboratories Ltd | 2,789 Cr. | 396 | 745/361 | 26.5 | 346 | 0.00 % | 6.24 % | 5.59 % | 2.00 |
| TTK Healthcare Ltd | 1,350 Cr. | 951 | 1,402/948 | 19.4 | 768 | 1.05 % | 9.26 % | 6.89 % | 10.0 |
| Torrent Pharmaceuticals Ltd | 1,33,426 Cr. | 3,939 | 4,125/2,886 | 61.6 | 250 | 0.81 % | 27.0 % | 26.5 % | 5.00 |
| Themis Medicare Ltd | 773 Cr. | 83.7 | 240/75.2 | | 41.3 | 0.60 % | 10.4 % | 7.65 % | 1.00 |
| Syncom Formulations (India) Ltd | 1,283 Cr. | 13.6 | 23.5/11.5 | 20.4 | 4.00 | 0.00 % | 18.6 % | 15.5 % | 1.00 |
| Cohance Lifesciences Ltd | 12,981 Cr. | 339 | 1,328/334 | 37.8 | 99.0 | 0.00 % | 14.9 % | 12.7 % | 1.00 |
| Suven Life Sciences Ltd | 3,717 Cr. | 160 | 303/102 | | 12.4 | 0.00 % | 87.0 % | 87.2 % | 1.00 |
| Sun Pharmaceuticals Industries Ltd | 4,06,783 Cr. | 1,695 | 1,851/1,547 | 33.5 | 324 | 0.94 % | 20.2 % | 16.9 % | 1.00 |
| Solara Active Pharma Sciences Ltd | 2,099 Cr. | 471 | 734/441 | | 347 | 0.00 % | 6.01 % | 0.05 % | 10.0 |
| SMS Pharmaceuticals Ltd | 2,974 Cr. | 318 | 360/175 | 36.7 | 81.2 | 0.13 % | 12.2 % | 11.0 % | 1.00 |
| SMS Lifesciences India Ltd | 357 Cr. | 1,197 | 1,680/956 | 20.6 | 650 | 0.13 % | 11.8 % | 10.8 % | 10.0 |
| Shilpa Medicare Ltd | 6,166 Cr. | 316 | 502/260 | 34.8 | 125 | 0.16 % | 7.82 % | 4.21 % | 1.00 |
| Sequent Scientific Ltd | 8,768 Cr. | 201 | 260/111 | 203 | 32.2 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
| Sanofi India Ltd | 9,210 Cr. | 4,001 | 6,718/3,976 | 24.9 | 340 | 2.92 % | 49.2 % | 47.2 % | 10.0 |
| RPG Life Sciences Ltd | 3,269 Cr. | 1,976 | 2,725/1,772 | 31.1 | 335 | 1.01 % | 32.8 % | 25.5 % | 8.00 |
| Procter & Gamble Health Ltd | 8,591 Cr. | 5,190 | 6,739/4,904 | 29.3 | 373 | 2.41 % | 47.8 % | 36.4 % | 10.0 |
| Pharmaids Pharmaceuticals Ltd | 138 Cr. | 39.2 | 76.2/37.1 | | 14.7 | 0.00 % | 17.4 % | 16.3 % | 10.0 |
| Pfizer Ltd | 21,017 Cr. | 4,590 | 5,993/3,701 | 29.7 | 841 | 0.76 % | 21.6 % | 16.4 % | 10.0 |
| Par Drugs & Chemicals Ltd | 113 Cr. | 91.7 | 195/81.0 | 11.6 | 86.5 | 0.00 % | 18.4 % | 13.6 % | 10.0 |
| Panacea Biotec Ltd | 2,238 Cr. | 363 | 582/281 | | 135 | 0.00 % | 4.57 % | 4.92 % | 1.00 |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
| Orchid Pharma Ltd | 3,438 Cr. | 681 | 1,498/604 | 65.8 | 251 | 0.00 % | 8.07 % | 8.21 % | 10.0 |
| Neuland Laboratories Ltd | 16,720 Cr. | 13,030 | 19,748/10,060 | 85.4 | 1,263 | 0.09 % | 18.7 % | 14.8 % | 10.0 |
| Nectar Lifescience Ltd | 261 Cr. | 13.4 | 38.9/13.0 | | 32.0 | 0.00 % | 5.36 % | 11.2 % | 1.00 |
| Natco Pharma Ltd | 14,735 Cr. | 824 | 1,341/660 | 9.58 | 483 | 0.73 % | 32.8 % | 28.0 % | 2.00 |
| Morepen Laboratories Ltd | 2,014 Cr. | 36.7 | 70.5/33.5 | 26.7 | 21.8 | 0.55 % | 15.1 % | 11.8 % | 2.00 |
| Marksans Pharma Ltd | 8,037 Cr. | 177 | 276/156 | 22.3 | 59.3 | 0.45 % | 20.0 % | 16.8 % | 1.00 |
| Mangalam Drugs and Organics Ltd | 56.4 Cr. | 35.7 | 116/22.7 | | 80.5 | 0.00 % | 8.03 % | 4.71 % | 10.0 |
| Lyka Labs Ltd | 252 Cr. | 70.6 | 142/67.8 | | 28.3 | 0.00 % | 9.91 % | 9.31 % | 10.0 |
| Lupin Ltd | 99,380 Cr. | 2,174 | 2,249/1,774 | 23.0 | 430 | 0.55 % | 21.3 % | 20.6 % | 2.00 |
| Lincoln Pharmaceuticals Ltd | 922 Cr. | 460 | 778/440 | 11.5 | 357 | 0.39 % | 17.3 % | 12.8 % | 10.0 |
| Laurus Labs Ltd | 51,268 Cr. | 951 | 1,141/512 | 64.0 | 91.1 | 0.13 % | 9.47 % | 7.75 % | 2.00 |
| Kwality Pharmaceuticals Ltd | 1,201 Cr. | 1,158 | 1,235/596 | 24.5 | 281 | 0.00 % | 18.2 % | 16.2 % | 10.0 |
| Krebs Biochemicals & Industries Ltd | 123 Cr. | 57.4 | 114/51.0 | | 73.2 | 0.00 % | 30.1 % | % | 10.0 |
| Kopran Ltd | 676 Cr. | 140 | 215/120 | 40.8 | 104 | 2.14 % | 9.75 % | 7.64 % | 10.0 |
| Kilitch Drugs (India) Ltd | 622 Cr. | 358 | 500/265 | 22.6 | 152 | 0.00 % | 15.7 % | 12.6 % | 10.0 |
| Jubilant Pharmova Ltd | 14,927 Cr. | 938 | 1,250/802 | 32.3 | 414 | 0.53 % | 9.54 % | 9.55 % | 1.00 |
| J B Chemicals & Pharmaceuticals Ltd | 29,696 Cr. | 1,850 | 1,939/1,303 | 39.4 | 243 | 0.84 % | 25.8 % | 20.1 % | 1.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,118 Cr. | 168 | 302/155 | 26.2 | 37.9 | 1.49 % | 23.0 % | 18.6 % | 2.00 |
| Ipca Laboratories Ltd | 35,881 Cr. | 1,417 | 1,595/1,168 | 36.2 | 293 | 0.28 % | 14.7 % | 12.8 % | 1.00 |
| IOL Chemicals & Pharmaceuticals Ltd | 2,221 Cr. | 75.6 | 127/57.5 | 19.1 | 59.7 | 1.06 % | 8.86 % | 6.13 % | 2.00 |
| Ind-Swift Ltd | 85.4 Cr. | 15.8 | 19.9/12.0 | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
| Ind-Swift Laboratories Ltd | 1,077 Cr. | 132 | 139/67.2 | 22.7 | 160 | 0.00 % | 0.78 % | 0.18 % | 10.0 |
| Indoco Remedies Ltd | 1,940 Cr. | 213 | 350/190 | | 106 | 0.09 % | 0.49 % | 7.02 % | 2.00 |
| Hikal Ltd | 2,212 Cr. | 180 | 457/177 | 219 | 96.9 | 0.78 % | 9.85 % | 7.38 % | 2.00 |
| Hester Biosciences Ltd | 1,282 Cr. | 1,510 | 2,350/1,243 | 31.3 | 397 | 0.46 % | 9.71 % | 9.18 % | 10.0 |
| Gufic BioSciences Ltd | 3,082 Cr. | 308 | 428/285 | 56.8 | 62.7 | 0.03 % | 13.2 % | 12.3 % | 1.00 |
| Granules India Ltd | 13,688 Cr. | 564 | 627/412 | 25.2 | 164 | 0.27 % | 15.1 % | 13.9 % | 1.00 |
| Glenmark Pharmaceuticals Ltd | 54,514 Cr. | 1,935 | 2,286/1,275 | 20.1 | 340 | 0.13 % | 19.4 % | 15.8 % | 1.00 |
| Glaxosmithkline Pharmaceuticals Ltd | 42,106 Cr. | 2,484 | 3,516/1,968 | 44.2 | 101 | 1.69 % | 63.2 % | 46.9 % | 10.0 |
| Gland Pharma Ltd | 30,487 Cr. | 1,851 | 2,131/1,200 | 25.7 | 610 | 0.97 % | 15.8 % | 11.6 % | 1.00 |
| FDC Ltd | 6,045 Cr. | 368 | 528/357 | 26.0 | 149 | 1.36 % | 15.9 % | 11.8 % | 1.00 |
| ERIS Lifesciences Ltd | 19,826 Cr. | 1,431 | 1,910/1,097 | 47.7 | 227 | 0.51 % | 12.2 % | 12.9 % | 1.00 |
| Dr Reddys Laboratories Ltd | 1,03,574 Cr. | 1,241 | 1,380/1,020 | 18.6 | 432 | 0.64 % | 22.7 % | 18.0 % | 1.00 |
| Dishman Carbogen Amcis Ltd | 3,150 Cr. | 201 | 322/178 | 23.9 | 406 | 0.00 % | 2.42 % | 0.32 % | 2.00 |
| Cipla Ltd | 1,07,483 Cr. | 1,330 | 1,673/1,282 | 22.6 | 408 | 0.98 % | 22.7 % | 17.8 % | 2.00 |
| Caplin Point Laboratories Ltd | 13,894 Cr. | 1,826 | 2,397/1,551 | 22.6 | 416 | 0.33 % | 25.8 % | 22.7 % | 2.00 |
| Brooks Laboratories Ltd | 178 Cr. | 60.9 | 166/58.4 | 12.7 | 39.3 | 0.00 % | 9.93 % | 12.2 % | 10.0 |
| Bliss GVS Pharma Ltd | 1,941 Cr. | 183 | 196/105 | 17.7 | 107 | 0.27 % | 11.7 % | 8.36 % | 1.00 |
| Biofil Chemicals & Pharmaceuticals Ltd | 58.7 Cr. | 35.9 | 58.0/28.5 | 20.6 | 13.1 | 0.00 % | 4.12 % | 3.03 % | 10.0 |
| Biocon Ltd | 59,244 Cr. | 365 | 425/291 | 125 | 200 | 0.14 % | 6.25 % | 4.76 % | 5.00 |
| Beta Drugs Ltd | 1,393 Cr. | 1,380 | 2,000/1,362 | 30.8 | 219 | 0.00 % | 27.0 % | 25.9 % | 10.0 |
| Bal Pharma Ltd | 109 Cr. | 69.9 | 129/64.0 | 15.9 | 49.2 | 1.72 % | 10.1 % | 9.66 % | 10.0 |
| Bafna Pharmaceuticals Ltd | 272 Cr. | 116 | 205/67.8 | 25.7 | 38.6 | 0.00 % | 8.34 % | 7.69 % | 10.0 |
| Astrazeneca Pharma India Ltd | 21,496 Cr. | 8,600 | 10,691/6,502 | 93.0 | 320 | 0.37 % | 33.4 % | 23.6 % | 2.00 |
| Amrutanjan Health Care Ltd | 1,835 Cr. | 634 | 791/544 | 31.7 | 118 | 0.73 % | 22.4 % | 16.5 % | 1.00 |
| Alpa Laboratories Ltd | 148 Cr. | 71.0 | 125/61.0 | 7.87 | 92.0 | 0.00 % | 15.0 % | 11.5 % | 10.0 |
| Alkem Laboratories Ltd | 67,967 Cr. | 5,684 | 5,934/4,492 | 28.9 | 1,116 | 0.79 % | 20.4 % | 19.4 % | 2.00 |
| Alembic Pharmaceuticals Ltd | 15,692 Cr. | 798 | 1,108/725 | 23.6 | 271 | 1.38 % | 13.0 % | 11.4 % | 2.00 |
| Albert David Ltd | 395 Cr. | 681 | 1,212/663 | | 690 | 0.73 % | 6.45 % | 4.39 % | 10.0 |
| Ajanta Pharma Ltd | 35,704 Cr. | 2,853 | 3,021/2,022 | 35.2 | 345 | 0.98 % | 32.4 % | 24.9 % | 2.00 |
| Advanced Enzyme Technologies Ltd | 3,221 Cr. | 287 | 367/258 | 22.4 | 133 | 1.81 % | 13.1 % | 9.54 % | 2.00 |
| Aarti Drugs Limited | 3,426 Cr. | 375 | 575/312 | 18.4 | 147 | 0.53 % | 13.5 % | 13.0 % | 10.0 |
| Industry Average | 19,603.26 Cr | 1,093.01 | | 42.95 | 202.24 | 0.37% | 16.29% | 15.20% | 6.10 |